On the other hand, many reports have demonstrated that PKR is overexpressed and activated in several kinds of malignant diseases, such as acute myeloid leukemia, acute lymphoblastic leukemia, colon cancer, breast cancer, and lung cancer20–23. The gene discussed is EIF2AK2; the disease is breast carcinoma.